Replies to post #358612 on Anavex Life Sciences Corp (AVXL)

[rayovacAAA]

PURE B.S.!!!!!!!!!!

I missed Misslings talk today, but here is some notes taken by a stocktwits poster:

Actually said Excellence said 2h (I think he’s being optimistic or they pushed the dates out further then they needed to avoid missing another deadline).

I'm glad to hear that he will PR when the trial finishes with the last patient completing, that was good news to hear. Evidently he has got an ear full about his former lack of communicating details the shareholder should be made aware of..

[jmvho]

Red & plexrec,

I watched this mornings presentation and will say that TGD is coming off as very comfortable and confident in making these presentations. The Stock Twits post sums it up quite well but I also feel TGD is doing a better job of explaining all the upstream
benefits of 2-73 and how much better it is than a drug that just targets amyloid/tau.

Early on in his presentation, he definitely covered the potential prophylactic market,
talking about how the animal studies showed 2-73 prevented AD. Once the MOA
is confirmed in the AD phase 2b/3 trial later this year, Wall Street might finally start
factoring in the enormous size of the prevention market in their calculations for
Anavex.

jmvho